Cargando…
Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528736/ https://www.ncbi.nlm.nih.gov/pubmed/34671866 http://dx.doi.org/10.1007/s00395-021-00903-6 |
_version_ | 1784586311672266752 |
---|---|
author | Michel, Lars Totzeck, Matthias Rassaf, Tienush |
author_facet | Michel, Lars Totzeck, Matthias Rassaf, Tienush |
author_sort | Michel, Lars |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8528736 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-85287362021-11-04 Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity Michel, Lars Totzeck, Matthias Rassaf, Tienush Basic Res Cardiol Editorial Springer Berlin Heidelberg 2021-10-20 2021 /pmc/articles/PMC8528736/ /pubmed/34671866 http://dx.doi.org/10.1007/s00395-021-00903-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Editorial Michel, Lars Totzeck, Matthias Rassaf, Tienush Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity |
title | Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity |
title_full | Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity |
title_fullStr | Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity |
title_full_unstemmed | Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity |
title_short | Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity |
title_sort | cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528736/ https://www.ncbi.nlm.nih.gov/pubmed/34671866 http://dx.doi.org/10.1007/s00395-021-00903-6 |
work_keys_str_mv | AT michellars cardiacdysfunctionfromcancerandcancertherapynewpathwaysforthepreventionoflatecardiotoxicity AT totzeckmatthias cardiacdysfunctionfromcancerandcancertherapynewpathwaysforthepreventionoflatecardiotoxicity AT rassaftienush cardiacdysfunctionfromcancerandcancertherapynewpathwaysforthepreventionoflatecardiotoxicity |